Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era

Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era

The atypical hemolytic uremic syndrome (aHUS) in the newborn is a rare disease, with high morbidity. Eculizumab, considered a first-line drug in older children, is not approved in neonates and in children weighing less than 5 kg. We present a 5-day-old female newborn, born at 36 weeks' twin ges...

Full description

Bibliographic Details
Main Authors: Sara Madureira Gomes, Rita Pissarra Teixeira, Gustavo Rocha, Paulo Soares, Hercilia Guimaraes, Paulo Santos, Joana Jardim, João Luís Barreira, Helena Pinto
Format: Article
Language:English
Published: Thieme Medical Publishers, Inc. 2021-04-01
Series:American Journal of Perinatology Reports
Subjects:
atypical hemolytic uremic syndrome
thrombotic microangiopathy
neonate
eculizumab
perinatal asphyxia
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731057

Internet

http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1731057

Similar Items